Search in:

Scandinavian Journal of Infectious Diseases Volume 41, 2009 - Issue 6-7

Submit an article Journal homepage

713

Views

CrossRef citations to date

Altmetric

Original Article

Determining SARS sub-clinical infection: A longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital

Zhen Yang From the Department of Science Research, Medical College of Chinese People's Armed Police Force, Tianjin

Shixin Wang Dongli Hospital, Tianjin, China

Qian Li From the Department of Science Research, Medical College of Chinese People's Armed Police Force, Tianjin

Yuming Li From the Department of Science Research, Medical College of Chinese People's Armed Police Force, Tianjin

Maoti Wei From the Department of Science Research, Medical College of Chinese People's Armed Police Force, Tianjin

Hongsheng Gao From the Department of Science Research, Medical College of Chinese People's Armed Police Force, Tianjin

Catherine Donovan Division of Community Health and Humanities, Faculty of Medicine, Memorial University of Newfoundland, Canada

Peizhong Peter Wang Division of Community Health and Humanities, Faculty of Medicine, Memorial University of Newfoundland, Canada; School of Public Health, Tianjin Medical University, ChinaCorrespondence[email protected]

show all

Pages 507-510 | Received 06 Feb 2009, Published online: 21 Jul 2009

Cite this article
https://doi.org/10.1080/00365540902919384

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Aşkı VURAL, Erdoğan ÖZ, Osman KÜÇÜKKELEPÇE, Bilengül ASLAN VURAL & Hakan Sezgin SAYİNER. (2024) Correlation between antibody levels and long-term symptoms in survivors of COVID-19: health outcomes and societal implications. Journal of Health Sciences and Medicine 7:1, pages 17-23.
Crossref

Irene Garcia-Fogeda, Hajar Besbassi, Ynke Larivière, Benson Ogunjimi, Steven Abrams & Niel Hens. (2023) Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review. Vaccine 41:25, pages 3701-3709.
Crossref

Maria del Carmen Domínguez-Horta, Anabel Serrano-Díaz, Mabel Hernández-Cedeño, Gillian Martínez-Donato & Gerardo Guillén-Nieto. (2023) A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation. Frontiers in Immunology 14.
Crossref

Danqi Wang, Yuejun Chen, Shan Xiang, Huiting Hu, Yujuan Zhan, Ying Yu, Jingwen Zhang, Pian Wu, Fei yue Liu, Tianhan Kai & Ping Ding. (2023) Recent advances in immunoassay technologies for the detection of human coronavirus infections. Frontiers in Cellular and Infection Microbiology 12.
Crossref

Yueting Tang, Jiayu Sun, Yumeng Yuan, Fen Yao, Bokun Zheng, Gui Yang, Wen Xie, Guangming Ye, Zhen Li, Xiaoyang Jiao & Yirong Li. (2022) Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown. BMC Infectious Diseases 22:1.
Crossref

Ali Hamady, JinJu Lee & Zuzanna A. Loboda. (2021) Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?. Infection 50:1, pages 11-25.
Crossref

Eamon O Murchu, Paula Byrne, Kieran A. Walsh, Paul G. Carty, Máire Connolly, Cillian De Gascun, Karen Jordan, Mary Keoghan, Kirsty K. O'Brien, Michelle O'Neill, Susan M. Smith, Conor Teljeur, Máirín Ryan & Patricia Harrington. (2020) Immune response following infection with SARS‐CoV ‐2 and other coronaviruses: A rapid review . Reviews in Medical Virology 31:2.
Crossref

Tanveer Ahmad, Rituparna Chaudhuri, Mohan C. Joshi, Ahmad Almatroudi, Arshad Husain Rahmani & Syed Mansoor Ali. (2020) COVID-19: The Emerging Immunopathological Determinants for Recovery or Death. Frontiers in Microbiology 11.
Crossref

Maoti Wei, Ning Yang, Fenghua Wang, Guoping Zhao, Hongwei Gao & Yuming Li. (2020) Epidemiology of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Disaster Medicine and Public Health Preparedness 14:6, pages 796-804.
Crossref

Robin Augustine, Suvarthi Das, Anwarul Hasan, Abhilash S, Shaheen Abdul Salam, Priya Augustine, Yogesh Bharat Dalvi, Ruby Varghese, Rosita Primavera, Hadi Mohamad Yassine, Avnesh S. Thakor & Bhavesh D. Kevadiya. (2020) Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World. Journal of Clinical Medicine 9:10, pages 3372.
Crossref

Angkana T. Huang, Bernardo Garcia-Carreras, Matt D. T. Hitchings, Bingyi Yang, Leah C. Katzelnick, Susan M. Rattigan, Brooke A. Borgert, Carlos A. Moreno, Benjamin D. Solomon, Luke Trimmer-Smith, Veronique Etienne, Isabel Rodriguez-Barraquer, Justin Lessler, Henrik Salje, Donald S. Burke, Amy Wesolowski & Derek A. T. Cummings. (2020) A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nature Communications 11:1.
Crossref

Sixten Körper, Bernd Jahrsdörfer, Thomas Appl, Harald Klüter, Erhard Seifried & Hubert Schrezenmeier. (2020) Rekonvaleszentenplasma zur Behandlung von schwerem COVID-19: Rationale und Design einer randomisierten, offenen klinischen Studie von Rekonvaleszentenplasma verglichen mit bestmöglicher supportiver Behandlung (CAPSID-Studie). Transfusionsmedizin - Immunhämatologie · Hämotherapie · Transplantationsimmunologie · Zelltherapie 10:03, pages 143-149.
Crossref

Grant Waterer. (2011) Controlling epidemic viral infection. Current Opinion in Infectious Diseases 24:2, pages 130-136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Determining SARS sub-clinical infection: A longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Determining SARS sub-clinical infection: A longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital

Citations (13)

Articles from other publishers (13)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date